Exploring Womens Experiences of Treatment for Binge Eating Disorder: Methylphenidate Vs. Cognitive Behavioural Therapy

Simple item page
dc.contributor.advisorDavis, Caroline A.
dc.contributor.authorMoghimi, Elnaz
dc.date.accessioned2021-07-06T12:42:27Z
dc.date.available2021-07-06T12:42:27Z
dc.date.copyright2021-02
dc.date.issued2021-07-06
dc.date.updated2021-07-06T12:42:26Z
dc.degree.disciplineKinesiology & Health Science
dc.degree.levelDoctoral
dc.degree.namePhD - Doctor of Philosophy
dc.description.abstractA previous randomized controlled trial (RCT) investigated methylphenidate (MP) and cognitive behavioural therapy (CBT) treatments in women with BED and a BMI 25. The following qualitative study enrolled 15 treatment completers (8 MP, 7 CBT) and four clinicians (3 CBT psychologists and 1 MP psychiatrist). The primary objectives were to explore the patients' and clinicians lived experiences of BED treatment. Informed by a phenomenological methodology, semi-structured interviews captured their narrative accounts. Key themes were then identified from transcribed audio recordings, using thematic analysis methods. The patients in both groups described the importance of mindfulness and self-awareness in helping them regain control over their food intake. In addition, a positive patient-clinician relationship was reported to be integral to treatment success as it acknowledged the need for safety and comfort in this group. Patients in the MP group described the drug's primary benefit to be appetite reduction, which decreased food preoccupation and binge frequency. Although the beneficial effects were not immediate in the CBT group, the patients appreciated obtaining a "toolbox of skills" to manage their binges. The clinicians corroborated the patients' general experiences of the treatments. They also described the importance of a collaborative clinician-patient relationship and the social determinants of health that affected treatment accessibility. Both clinicians and patients saw stress as a reason to binge or relapse. Therefore, it is proposed that treatments have a stronger focus on adaptive stress-coping skills. Taken together, these qualitative findings add a much-needed perspective on clinical treatments for compulsive overeating. The study is especially important considering that a psychomotor stimulant similar to MP is the only approved pharmacotherapy for BED and to date, little is known about the patient's subjective experiences.
dc.identifier.urihttp://hdl.handle.net/10315/38435
dc.languageen
dc.rightsAuthor owns copyright, except where explicitly noted. Please contact the author directly with licensing requests.
dc.subjectClinical psychology
dc.subject.keywordsbinge eating disorder
dc.subject.keywordsBED
dc.subject.keywordscompulsive overeating
dc.subject.keywordscognitive behavioural therapy
dc.subject.keywordsCBT
dc.subject.keywordspsychostimulant
dc.subject.keywordspsychomotor stimulant
dc.subject.keywordsmethylphenidate
dc.subject.keywordsqualitative methods
dc.subject.keywordsthematic analysis
dc.subject.keywordseating disorder
dc.titleExploring Womens Experiences of Treatment for Binge Eating Disorder: Methylphenidate Vs. Cognitive Behavioural Therapy
dc.typeElectronic Thesis or Dissertation

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
FINAL_Moghimi_Elnaz_2021_PhD.pdf
Size:
1.78 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
license.txt
Size:
1.87 KB
Format:
Plain Text
Description:
Download
No Thumbnail Available
Name:
YorkU_ETDlicense.txt
Size:
3.39 KB
Format:
Plain Text
Description:
Download

Collections

Kinesiology & Health Science

All items in the YorkSpace institutional repository are protected by copyright, with all rights reserved except where explicitly noted.